Hans Lennart Rudolf Wigzell

Hans Lennart Rudolf Wigzell

Fortune : 752 291 $ au 31/05/2026

87 ans
Health Technology
Commercial Services
Finance

Profil

Hans Lennart Rudolf Wigzell founded Affibody Medical AB in 1998.
Dr. Wigzell also currently works at RaySearch Laboratories AB, as Chairman from 2022, Stockholm School of Entrepreneurship, as Chairman, PRFA Management AB, as Chairman, Biochromix Newco AB, as Chairman, Sarepta Therapeutics, Inc., as Independent Director from 2012, Humabs LLC, as Director from 2012, Gapminder Foundation, as Director, Wigzellproduktion AB, as Director, Royal Swedish Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, Royal Swedish Academy of Engineering Sciences, as Member, European Molecular Biology Organization, as Member, Finnish Society of Sciences & Letters, as Member, and Royal Danish Academy of Sciences & Letters, as Member.
Dr. Wigzell also formerly worked at Rhenman & Partners Asset Management AB, as Chairman, KDventures AB, as Chairman from 2017 to 2020, ExThera AB, as Chairman, Intercell AG, as Director, Mertiva AB, as Director, NeoDynamics AB, as Director, Swedish Orphan Biovitrum AB, as Independent Director, Smittskyddsinstitutet, as General Director, Cadila Pharmaceuticals Sweden AB, as Director, National Bacteriological Laboratory, as General Director from 1987 to 1993, Probi AB, as Member-Supervisory Board, Biovitrum AB, as Member-Supervisory Board, Epixis SA, as Member-Supervisory Board, Valneva SE, as Independent Member-Supervisory Board from 2013 to 2016, and Karolinska Institutet, as President from 1995 to 2003.
Dr. Wigzell received his doctorate degree in 1967 from Karolinska Institutet.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 42 098 ( 0,04 % ) 752 291 $ 31/05/2026

Postes actifs de Hans Lennart Rudolf Wigzell

SociétésPosteDébut
RAYSEARCH LABORATORIES AB Président 30/09/2022
SAREPTA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/06/2010
Wigzellproduktion AB
Directeur/Membre du Conseil -
Biochromix Newco AB
Président -
PRFA Management AB
Président -
Royal Danish Academy of Sciences & Letters
Corporate Officer/Principal -
Président -
European Molecular Biology Organization
Corporate Officer/Principal -
Finnish Society of Sciences & Letters
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Anciens postes connus de Hans Lennart Rudolf Wigzell

SociétésPosteFin
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Hans Lennart Rudolf Wigzell

Formation de Hans Lennart Rudolf Wigzell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées30

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Technology Services

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

European Molecular Biology Organization

Finance

Health Technology

Health Technology

Health Technology

Finnish Society of Sciences & Letters

Technology Services

Smittskyddsinstitutet

Royal Danish Academy of Sciences & Letters

Finance

Wigzellproduktion AB

Health Technology

Consumer Services

Health Technology

PRFA Management AB

Health Technology

Biochromix Newco AB

National Bacteriological Laboratory

  1. Bourse
  2. Insiders
  3. Hans Lennart Rudolf Wigzell
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇